CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study with primary objective of looking whether YPT-01 phage therapy
reduces sputum bacterial load in cystic fibrosis subjects with Pseudomonas aeruginosa.
In addition, study evaluates the safety profile of phage therapy in this patient population.